A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.

Michael Friedlander, Tarek Meniawy, Ben Markman, Linda R. Mileshkin, Paul R. Harnett, Michael Millward, Joanne Lundy, Alison E. Freimund, Christie Norris, Song Mu, John Wu, Virginia E. Paton, Lai Wang, Bo Gao

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Number of pages5
JournalJournal of Clinical Oncology
Volume35
DOIs
Publication statusPublished - 20 May 2017
Event53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States
Duration: 2 Jun 20176 Jun 2017

Cite this

Friedlander, Michael ; Meniawy, Tarek ; Markman, Ben ; Mileshkin, Linda R. ; Harnett, Paul R. ; Millward, Michael ; Lundy, Joanne ; Freimund, Alison E. ; Norris, Christie ; Mu, Song ; Wu, John ; Paton, Virginia E. ; Wang, Lai ; Gao, Bo. / A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors. In: Journal of Clinical Oncology. 2017 ; Vol. 35.
@article{16be70579575471095bc1a2f4f7c382f,
title = "A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.",
author = "Michael Friedlander and Tarek Meniawy and Ben Markman and Mileshkin, {Linda R.} and Harnett, {Paul R.} and Michael Millward and Joanne Lundy and Freimund, {Alison E.} and Christie Norris and Song Mu and John Wu and Paton, {Virginia E.} and Lai Wang and Bo Gao",
year = "2017",
month = "5",
day = "20",
doi = "10.1200/JCO.2017.35.15_suppl.3013",
language = "English",
volume = "35",
journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",

}

A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors. / Friedlander, Michael; Meniawy, Tarek; Markman, Ben; Mileshkin, Linda R.; Harnett, Paul R.; Millward, Michael; Lundy, Joanne; Freimund, Alison E.; Norris, Christie; Mu, Song; Wu, John; Paton, Virginia E.; Wang, Lai; Gao, Bo.

In: Journal of Clinical Oncology, Vol. 35, 20.05.2017.

Research output: Contribution to journalAbstract/Meeting Abstract

TY - JOUR

T1 - A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.

AU - Friedlander, Michael

AU - Meniawy, Tarek

AU - Markman, Ben

AU - Mileshkin, Linda R.

AU - Harnett, Paul R.

AU - Millward, Michael

AU - Lundy, Joanne

AU - Freimund, Alison E.

AU - Norris, Christie

AU - Mu, Song

AU - Wu, John

AU - Paton, Virginia E.

AU - Wang, Lai

AU - Gao, Bo

PY - 2017/5/20

Y1 - 2017/5/20

U2 - 10.1200/JCO.2017.35.15_suppl.3013

DO - 10.1200/JCO.2017.35.15_suppl.3013

M3 - Abstract/Meeting Abstract

VL - 35

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

SN - 0732-183X

ER -